These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. An algorithm for managing the failure of external beam radiotherapy in prostate cancer. Dudderidge T; Payne H; Emberton M BJU Int; 2007 Sep; 100(3):518-27. PubMed ID: 17573894 [TBL] [Abstract][Full Text] [Related]
27. When should the seminal vesicles be included in the target volume in prostate radiotherapy? Bayman NA; Wylie JP Clin Oncol (R Coll Radiol); 2007 Jun; 19(5):302-7. PubMed ID: 17448647 [TBL] [Abstract][Full Text] [Related]
28. Prostate-specific antigen level at initiation of hormonal therapy after prostate-specific antigen failure following prostatectomy or radiotherapy and therapeutic response. Alexander BM; Chen MH; Carroll P; D'Amico AV Urology; 2007 Aug; 70(2):320-3. PubMed ID: 17826497 [TBL] [Abstract][Full Text] [Related]
29. Reduction of irradiation volume and toxicities with 3-D radiotherapy planning over conventional radiotherapy for prostate cancer treated with long-term hormonal therapy. Yamazaki H; Nishiyama K; Tanaka E; Maeda O; Meguro N; Kinouchi T; Usami M; Kakimoto K; Ono Y; Nishimura T Anticancer Res; 2008; 28(6B):3913-20. PubMed ID: 19192649 [TBL] [Abstract][Full Text] [Related]
30. [PSA bounce after permanent implant prostate brachytherapy may mimic a biochemical failure]. Toledano A; Chauveinc L; Flam T; Thiounn N; Solignac S; Timbert M; Rosenwald JC; Cosset JM Cancer Radiother; 2007 May; 11(3):105-10. PubMed ID: 17158082 [TBL] [Abstract][Full Text] [Related]
31. Is it possible to compare PSA recurrence-free survival after surgery and radiotherapy using revised ASTRO criterion--"nadir + 2"? Nielsen ME; Makarov DV; Humphreys E; Mangold L; Partin AW; Walsh PC Urology; 2008 Aug; 72(2):389-93; discussion 394-5. PubMed ID: 18279937 [TBL] [Abstract][Full Text] [Related]
33. Usefulness of ultrasensitive prostate-specific antigen assay for early detection of biochemical failure after radical prostatectomy. Nakamura M; Hasumi H; Miyoshi Y; Sugiura S; Fujinami K; Yao M; Kubota Y; Uemura H Int J Urol; 2005 Dec; 12(12):1050-4. PubMed ID: 16409609 [TBL] [Abstract][Full Text] [Related]
34. Percentages of positive cores, cancer length and Gleason grade 4/5 cancer in systematic sextant biopsy are all predictive of adverse pathology and biochemical failure after radical prostatectomy. Suekane S; Noguchi M; Nakashima O; Yamada S; Kojiro M; Matsuoka K Int J Urol; 2007 Aug; 14(8):713-8. PubMed ID: 17681061 [TBL] [Abstract][Full Text] [Related]
35. The actual value of the surgical margin status as a predictor of disease progression in men with early prostate cancer. Vis AN; Schröder FH; van der Kwast TH Eur Urol; 2006 Aug; 50(2):258-65. PubMed ID: 16413660 [TBL] [Abstract][Full Text] [Related]
36. Percentage of cancer in prostate biopsies as prognostic factor for staging and postoperative biochemical failure after radical prostatectomy. Villamón-Fort R; Martínez-Jabaloyas JM; Soriano-Sarriá P; Ramos-Soler D; Pastor-Hernández F; Gil-Salom M Urol Int; 2007; 78(4):328-33. PubMed ID: 17495491 [TBL] [Abstract][Full Text] [Related]
37. Predicting PSA failure following salvage radiotherapy for a rising PSA post-prostatectomy: from the CaPSURE database. Macdonald OK; D'Amico AV; Sadetsky N; Shrieve DC; Carroll PR Urol Oncol; 2008; 26(3):271-5. PubMed ID: 18452818 [TBL] [Abstract][Full Text] [Related]
38. PSA bounce after permanent implant prostate brachytherapy may mimic a biochemical failure: a study of 295 patients with a minimum 3-year followup. Toledano A; Chauveinc L; Flam T; Thiounn N; Solignac S; Timbert M; Rosenwald JC; Cosset JM Brachytherapy; 2006; 5(2):122-6. PubMed ID: 16644467 [TBL] [Abstract][Full Text] [Related]
39. [Elevation of PSA after prostate radiotherapy: rebound or biochemical recurrence?]. Toledano A; Chiche R; Lamallem H; Kanoui A; Beley S; Thibault F; Sèbe P Prog Urol; 2008 Oct; 18(9):557-61. PubMed ID: 18986625 [TBL] [Abstract][Full Text] [Related]
40. Pre-operative percent free PSA predicts clinical outcomes in patients treated with radical prostatectomy with total PSA levels below 10 ng/ml. Shariat SF; Abdel-Aziz KF; Roehrborn CG; Lotan Y Eur Urol; 2006 Feb; 49(2):293-302. PubMed ID: 16387412 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]